{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027936","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2026-06-09T20:15:25+00:00","discovered_at":"2026-06-09T20:16:00.253991+00:00","generated_at":"2026-06-09T20:16:18.967112+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Sanara MedTech annual meeting results: all proposals approved; board adopts triennial advisory vote on exec comp","bullets":["All nine director nominees elected, with each receiving >5M for votes (including Yon, Nixon, DeSutter).","Weaver and Tidwell ratified as auditor for FY2026: 6,696,035 for, 2,198 against.","Advisory say-on-pay approved: 5,280,546 for (98.9% of votes cast).","Frequency vote favors three years (4,296,133); board sets triennial advisory vote on exec comp, next vote in 2029."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027936","json":"https://secwatch.observer/filing/0001493152-26-027936.json","markdown":"https://secwatch.observer/filing/0001493152-26-027936.md","text":"https://secwatch.observer/filing/0001493152-26-027936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T20:16:18.967112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"37e67906f60425cf4d943216ba299f5b1d5861fd","claim":"Sanara MedTech Inc. shareholders approved Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 2 : Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"4c53b6f08527e1b35b5cc5e288866cd70f73a02d","claim":"Sanara MedTech Inc. shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"9b6594a58e28e1882511cf93092bffb136f36a1b","claim":"Sanara MedTech Inc. shareholders approved Advisory vote on the frequency of future advisory votes on named executive officer compensation at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 4 : Approval, on an advisory basis, of the frequency of future advisory votes on named executive officer compensation.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"f05dc11c1aa7597a92d90d8a6889452375052a65","claim":"Sanara MedTech Inc. shareholders approved Election of nine directors to serve for a one-year term until 2027 annual meeting at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 1 : Election of (i) Seth D. Yon, (ii) Ronald T. Nixon, (iii) Robert A. DeSutter, (iv) Roszell Mack III, (v) Eric D. Major, (vi) Keith G. Myers, (vii) Sara N. Ortwein, (viii) Ann Beal Salamone and (ix) Eric D. Tanzberger to the Board of Directors of the Company, each to serve for a one-year term until the annual meeting of shareholders to be held in 2027 and until his or her successor is elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}